Littlejohn & Co’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-164,663
Closed -$4.08M 37
2023
Q3
$4.08M Sell
164,663
-132,990
-45% -$3.35M 3.47% 8
2023
Q2
$8.36M Buy
297,653
+11,647
+4% +$289K 5.82% 7
2023
Q1
$6.38M Buy
+286,006
New +$7.49M 3.82% 8
2022
Q2
Sell
-68,227
Closed -$1.28M 165
2022
Q1
$1.48M Buy
+68,227
New +$1.48M 0.39% 32
2021
Q4
Sell
-647,212
Closed -$13.7M 178
2021
Q3
$13.7M Buy
647,212
+151,416
+31% +$2.84M 3.95% 7
2021
Q2
$8.19M Buy
495,796
+478,880
+2,831% +$7.31M 2.41% 14
2021
Q1
$211K Buy
+16,916
New +$179K 0.06% 117

Other funds holding CCRN

Littlejohn & Co's CCRN Position: Q4 2023 in Review

Littlejohn & Co sold out of Cross Country Healthcare (CCRN) in Q4 2023, closing a stake of 164,663 shares — an estimated $4.08M sold.

Littlejohn & Co first reported a position in CCRN in Q1 2021 and held it in 7 quarters. The position peaked at $13.7M in Q3 2021. 175 funds tracked by Wall St. Rank hold CCRN as of Q4 2023.

  • Littlejohn & Co reported no remaining Cross Country Healthcare position as of Q4 2023 after selling out during the quarter.
  • Littlejohn & Co sold 164,663 Cross Country Healthcare shares in Q4 2023, an estimated $4.08M.
  • Littlejohn & Co first reported a position in Cross Country Healthcare in Q1 2021 and held it in 7 quarters.
  • Littlejohn & Co's Cross Country Healthcare position peaked at $13.7M in Q3 2021.
  • 175 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q4 2023.

Based on Littlejohn & Co's 13F filing for Q4 2023, filed 13 Feb 2024.